Synovial sarcoma: Clinicopathologic features, treatment, and prognosis

Herrick J. Siegel, Wade Sessions, Mark A. Casillas, Nasser Said-Al-Naief, Philip H. Lander, Robert Lopez-Ben

Research output: Contribution to journalArticle

37 Citations (Scopus)

Abstract

Synovial sarcoma is a characteristic subtype of soft tissue sarcomas with a predilection for young people. There may be a long delay in diagnosis or misdiagnosis, because of its insidious growth, varied presentation on imaging studies and associated joint pain, which can be confused with trauma. Diagnosis requires a tissue sample in the form of a needle or open biopsy. The needle biopsy may not be representative of the tumor, particular if it is biphasic, and it may be necessary to proceed to open biopsy. Ideally, the biopsy should be performed by the surgeon who will be performing the definitive surgical resection. Although treatment is predicated on surgery, adjuvant radiation and/or chemotherapy may be beneficial, particularly in high risk patients. Significant prognostic factors include: size >5 cm, deep-seated location, adequacy of surgical margins, and history of recurrence. In the future, multi-institutional prospectively randomized, controlled studies will be needed to better define the role of adjuvant chemotherapy. Currently, outcome may be optimized by early suspicion and detection with referral to an orthopedic oncology specialist prior to the biopsy.

Original languageEnglish (US)
Pages (from-to)1020-1025
Number of pages6
JournalOrthopedics
Volume30
Issue number12
StatePublished - Dec 2007
Externally publishedYes

Fingerprint

Synovial Sarcoma
Biopsy
Arthralgia
Needle Biopsy
Therapeutics
Adjuvant Chemotherapy
Diagnostic Errors
Sarcoma
Needles
Orthopedics
Referral and Consultation
Radiation
Recurrence
Drug Therapy
Wounds and Injuries
Growth
Neoplasms

ASJC Scopus subject areas

  • Orthopedics and Sports Medicine
  • Surgery

Cite this

Siegel, H. J., Sessions, W., Casillas, M. A., Said-Al-Naief, N., Lander, P. H., & Lopez-Ben, R. (2007). Synovial sarcoma: Clinicopathologic features, treatment, and prognosis. Orthopedics, 30(12), 1020-1025.

Synovial sarcoma : Clinicopathologic features, treatment, and prognosis. / Siegel, Herrick J.; Sessions, Wade; Casillas, Mark A.; Said-Al-Naief, Nasser; Lander, Philip H.; Lopez-Ben, Robert.

In: Orthopedics, Vol. 30, No. 12, 12.2007, p. 1020-1025.

Research output: Contribution to journalArticle

Siegel, HJ, Sessions, W, Casillas, MA, Said-Al-Naief, N, Lander, PH & Lopez-Ben, R 2007, 'Synovial sarcoma: Clinicopathologic features, treatment, and prognosis', Orthopedics, vol. 30, no. 12, pp. 1020-1025.
Siegel HJ, Sessions W, Casillas MA, Said-Al-Naief N, Lander PH, Lopez-Ben R. Synovial sarcoma: Clinicopathologic features, treatment, and prognosis. Orthopedics. 2007 Dec;30(12):1020-1025.
Siegel, Herrick J. ; Sessions, Wade ; Casillas, Mark A. ; Said-Al-Naief, Nasser ; Lander, Philip H. ; Lopez-Ben, Robert. / Synovial sarcoma : Clinicopathologic features, treatment, and prognosis. In: Orthopedics. 2007 ; Vol. 30, No. 12. pp. 1020-1025.
@article{9d3533d991a642fca32850b649bd171a,
title = "Synovial sarcoma: Clinicopathologic features, treatment, and prognosis",
abstract = "Synovial sarcoma is a characteristic subtype of soft tissue sarcomas with a predilection for young people. There may be a long delay in diagnosis or misdiagnosis, because of its insidious growth, varied presentation on imaging studies and associated joint pain, which can be confused with trauma. Diagnosis requires a tissue sample in the form of a needle or open biopsy. The needle biopsy may not be representative of the tumor, particular if it is biphasic, and it may be necessary to proceed to open biopsy. Ideally, the biopsy should be performed by the surgeon who will be performing the definitive surgical resection. Although treatment is predicated on surgery, adjuvant radiation and/or chemotherapy may be beneficial, particularly in high risk patients. Significant prognostic factors include: size >5 cm, deep-seated location, adequacy of surgical margins, and history of recurrence. In the future, multi-institutional prospectively randomized, controlled studies will be needed to better define the role of adjuvant chemotherapy. Currently, outcome may be optimized by early suspicion and detection with referral to an orthopedic oncology specialist prior to the biopsy.",
author = "Siegel, {Herrick J.} and Wade Sessions and Casillas, {Mark A.} and Nasser Said-Al-Naief and Lander, {Philip H.} and Robert Lopez-Ben",
year = "2007",
month = "12",
language = "English (US)",
volume = "30",
pages = "1020--1025",
journal = "Orthopedics",
issn = "0147-7447",
publisher = "Slack Incorporated",
number = "12",

}

TY - JOUR

T1 - Synovial sarcoma

T2 - Clinicopathologic features, treatment, and prognosis

AU - Siegel, Herrick J.

AU - Sessions, Wade

AU - Casillas, Mark A.

AU - Said-Al-Naief, Nasser

AU - Lander, Philip H.

AU - Lopez-Ben, Robert

PY - 2007/12

Y1 - 2007/12

N2 - Synovial sarcoma is a characteristic subtype of soft tissue sarcomas with a predilection for young people. There may be a long delay in diagnosis or misdiagnosis, because of its insidious growth, varied presentation on imaging studies and associated joint pain, which can be confused with trauma. Diagnosis requires a tissue sample in the form of a needle or open biopsy. The needle biopsy may not be representative of the tumor, particular if it is biphasic, and it may be necessary to proceed to open biopsy. Ideally, the biopsy should be performed by the surgeon who will be performing the definitive surgical resection. Although treatment is predicated on surgery, adjuvant radiation and/or chemotherapy may be beneficial, particularly in high risk patients. Significant prognostic factors include: size >5 cm, deep-seated location, adequacy of surgical margins, and history of recurrence. In the future, multi-institutional prospectively randomized, controlled studies will be needed to better define the role of adjuvant chemotherapy. Currently, outcome may be optimized by early suspicion and detection with referral to an orthopedic oncology specialist prior to the biopsy.

AB - Synovial sarcoma is a characteristic subtype of soft tissue sarcomas with a predilection for young people. There may be a long delay in diagnosis or misdiagnosis, because of its insidious growth, varied presentation on imaging studies and associated joint pain, which can be confused with trauma. Diagnosis requires a tissue sample in the form of a needle or open biopsy. The needle biopsy may not be representative of the tumor, particular if it is biphasic, and it may be necessary to proceed to open biopsy. Ideally, the biopsy should be performed by the surgeon who will be performing the definitive surgical resection. Although treatment is predicated on surgery, adjuvant radiation and/or chemotherapy may be beneficial, particularly in high risk patients. Significant prognostic factors include: size >5 cm, deep-seated location, adequacy of surgical margins, and history of recurrence. In the future, multi-institutional prospectively randomized, controlled studies will be needed to better define the role of adjuvant chemotherapy. Currently, outcome may be optimized by early suspicion and detection with referral to an orthopedic oncology specialist prior to the biopsy.

UR - http://www.scopus.com/inward/record.url?scp=38749095208&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=38749095208&partnerID=8YFLogxK

M3 - Article

C2 - 18198773

AN - SCOPUS:38749095208

VL - 30

SP - 1020

EP - 1025

JO - Orthopedics

JF - Orthopedics

SN - 0147-7447

IS - 12

ER -